Journal:
:hepatitis monthly
0
christine hartoonian department of pharmaceutical biotechnology and biotechnology research center, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran; department of virology, pasteur institute of iran, tehran, ir iran
zargham sepehrizadeh department of pharmaceutical biotechnology and biotechnology research center, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran; department of pharmaceutical biotechnology and biotechnology research center, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran. tel: +98-2164122301, fax: + 98-2166461178, e-mail: kayhan azadmanesh, department of virology, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166496682
mojtaba tabatabai yazdi department of pharmaceutical biotechnology and biotechnology research center, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran
yong suk jang departments of molecular biology and bioactive material sciences, institute for molecular biology and genetics, chonbuk national university, jeonju, korea
lida langroudi department of virology, pasteur institute of iran, tehran, ir iran
parisa amir kalvanagh department of virology, pasteur institute of iran, tehran, ir iran; department of immunology, faculty of medical sciences, tarbiat modaress university, tehran, ir iran
conclusions these results exhibited the immuno potentiator effects of mip-3beta plasmid when coadministrated with the hcv core dna vaccine. complimentary studies integrating mip-3beta as a genetic adjuvant in hcv-core-dna vaccination models are warranted. results mice covaccinated with mip-3beta elicited an enhanced th1 biased systemic immune response as evidenced by higher ifn-γ/il-4 and anti-...